首页> 外文期刊>Biotechnology Progress >Scale-Up of Breast Cancer Stem Cell Aggregate Cultures to Suspension Bioreactors
【24h】

Scale-Up of Breast Cancer Stem Cell Aggregate Cultures to Suspension Bioreactors

机译:乳腺癌干细胞聚集培养物按比例放大至悬浮生物反应器

获取原文
获取原文并翻译 | 示例
           

摘要

It has been hypothesized that breast tumor formation results from the activity of a scarce population of cells known as Breast Cancer Stem Cells (BrCSCs)and that the development of effective breast cancer therapies may therefore ultimately rely upon the ability to effectively target these cells for eradication.The scarcity of BrCSCs in vivo severely compromises research on these populations,as analyses are restricted to those requiring small cell numbers,and has become a major impediment to the development of therapeutic strategies against breast cancer.Through the culture of murine tissue aggregates containing a population of BrCSCs,this study demonstrates the ability of propagating this scarce population in a controlled and reproducible manner,within suspension bioreactors.A rigorous theoretical framework has been developed in order to understand and characterize the implications of oxygen mass transfer within aggregates upon scale-up and thereby provide a foundation for the scale-up of aggregate cultures.A two-factor,two-level factorial experimental design was also performed in order to assess the effects of inoculation density and hydrodynamic shear upon cell yield.We discovered that the culture of the murine aggregates in a relatively low shear environment (tau_(max)=0.20 Pa)and inoculated at 3.50 x 10~4 cells/mL resulted in the best yields for the range of conditions investigated in suspension bioreactors.A detailed study on the oxygen uptake kinetics of the aggregates also revealed that the uptake rates were not significantly affected by mass transfer limitations,as uptake rates of aggregate cultures were found to be comparable to those observed in single cell cultures.Cells propagated in a process controlled 500 mL suspension bioreactor resulted in growth kinetics that were comparable to those observed in 125 mL bioreactors.Doubling times in the 500 mL vessel were found to be 23.9 h and attained a maximum cell density of 1.20 x 10_6 cells/mL.After enumerating the number of BrCSCs,this resulted in an approximately 20-fold increase in BrCSC numbers in batch suspension cultures.With greater attention being applied to BrCSCs,their propagation in suspension bioreactors makes available experimental avenues that are not currently accessible and may thereby enable the development of more effective therapeutic drugs for the treatment of breast cancer.
机译:据推测,乳腺癌的形成是由称为乳腺癌干细胞(BrCSCs)的稀少细胞的活动导致的,因此有效的乳腺癌治疗方法的发展最终可能取决于有效靶向这些细胞以根除的能力体内BrCSCs的缺乏严重损害了对这些人群的研究,因为分析仅限于需要少量细胞的人群,并且已成为发展针对乳腺癌的治疗策略的主要障碍。 BrCSCs的数量,这项研究表明了在悬浮生物反应器内以可控和可复制的方式繁殖这种稀有种群的能力。已经建立了严格的理论框架,以了解和表征规模放大时聚集体内氧气质量转移的影响。从而为扩大规模提供基础为了评估接种密度和流体动力剪切对细胞产量的影响,还进行了两因素,两因素析因实验设计。我们发现鼠类聚集体的培养是在相对较低的剪切环境下进行的( tau_(max)= 0.20 Pa)并以3.50 x 10〜4细胞/ mL的接种量在悬浮生物反应器中研究的条件范围内获得了最佳产量。对聚集体的氧吸收动力学的详细研究也显示出速率不受传质限制的显着影响,因为聚集培养物的摄取率与单细胞培养物中观察到的相当。在过程控制的500 mL悬浮生物反应器中繁殖的细胞所产生的生长动力学与125 mL生物反应器。在500 mL容器中加倍时间为23.9小时,最大细胞密度为1.20 x 10_6细胞/ mL。随着BrCSCs数量的增加,分批悬浮培养物中的BrCSC数量增加了约20倍。随着对BrCSCs的更多关注,它们在悬浮生物反应器中的繁殖提供了目前尚不可用的实验途径,因此可能使开发更有效的治疗乳腺癌的药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号